Carregant...
Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential
Severe asthma is characterized by major impairment of quality of life, poor symptom control and frequent exacerbations. Inflammatory, clinical and causative factors identify different phenotypes and endotypes of asthma. In the last few years, new treatment options have allowed for targeted treatment...
Guardat en:
| Publicat a: | Ther Adv Chronic Dis |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5076744/ https://ncbi.nlm.nih.gov/pubmed/27803792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622316659863 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|